Profound Medical Corp. - Common Shares (PROF)

Historical Holders from Q4 2019 to Q3 2025

Symbol
PROF on Nasdaq
Type / Class
Equity / Common Shares
Shares outstanding
29,881,634
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
11,063,194
Holdings value
$54,283,775
% of all portfolios
0%
Number of holders
43
Number of buys
16
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Profound Medical Corp. - Common Shares (PROF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GAGNON SECURITIES LLC 11.2% $15,796,627 3,346,743 Neil Gagnon 31 Dec 2024

Institutional Holders of Profound Medical Corp. - Common Shares (PROF)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 11,063,194 $54,283,775 -$7,406,922 $4.89 43
2025 Q2 12,482,340 $73,650,616 -$2,042,016 $5.90 44
2025 Q1 12,825,851 $73,303,109 -$7,205,786 $5.82 48
2024 Q4 13,763,555 $102,960,287 +$30,141,003 $7.51 51
2024 Q3 9,406,781 $74,869,184 -$1,117,706 $7.96 42
2024 Q2 9,510,240 $80,047,787 -$132,453 $8.39 37
2024 Q1 9,500,142 $80,114,995 +$2,238,848 $8.53 39
2023 Q4 9,251,176 $77,759,535 +$10,244,275 $8.49 45
2023 Q3 7,489,374 $75,450,155 -$1,487,679 $10.20 30
2023 Q2 7,634,234 $98,724,050 -$1,129,044 $13.01 29
2023 Q1 7,726,121 $71,704,219 -$6,964,776 $9.29 30
2022 Q4 8,472,949 $91,726,796 +$3,083,523 $10.89 33
2022 Q3 8,745,198 $35,381,959 -$177,655 $4.04 30
2022 Q2 8,675,590 $63,032,248 -$3,670,846 $7.29 34
2022 Q1 9,402,835 $84,635,691 -$3,611,432 $9.00 41
2021 Q4 9,774,988 $109,777,858 -$2,915,423 $11.24 44
2021 Q3 8,722,358 $127,589,352 -$1,309,423 $14.64 46
2021 Q2 8,722,951 $142,593,346 -$126,994 $16.36 46
2021 Q1 8,673,835 $174,440,609 +$8,178,699 $20.14 52
2020 Q4 8,182,487 $168,377,436 +$26,332,305 $20.56 53
2020 Q3 7,009,150 $123,510,789 +$42,298,243 $17.64 44
2020 Q2 4,612,581 $78,146,000 -$131,017 $16.94 33
2020 Q1 4,764,927 $46,182,000 +$27,289,444 $9.74 31
2019 Q4 1,948,600 $21,824,000 +$21,824,000 $10.98 16